Efficacy and tolerability of pharmacotherapy for obsessive-compulsive personality disorder: a systematic review of randomized controlled trials — Julija Gečaitė-Stončienė (2022) | RDL Network
Efficacy and tolerability of pharmacotherapy for obsessive-compulsive personality disorder: a systematic review of randomized controlled trials
Article 2022 en
Authors
JG
Julija Gečaitė-Stončienė
TW
Taryn Williams
CL
Christine Löchner
Abstract
1 min read
Two studies provide preliminary evidence in support of citalopram and fluvoxamine for OCPD. Further randomized controlled trials are required before firm conclusions can be drawn regarding efficacy of pharmacotherapy for OCPD.
Discussion(0)
No comments yet. Be the first to comment.